When the FDA tells you to clean up your act, it’s best not to make the regulator ask twice. Now, one Chinese drugmaker is learning that lesson the hard way. The FDA has scolded Zhejiang Tianyu ...

In the summer of 2018, the FDA learned that some generic ARB medications, including valsartan, irbesartan, losartan and others contained nitrosamine impurities— including N-Nitrosodimethylamine (NDMA) ...